AstraZeneca rejects reports on vaccine efficacy in elderly

KSEB plans to generate 1,000 MW of solar power by next year

Germany’s Health Ministry on Tuesday joined AstraZeneca in rubbishing reports quoting unnamed government sources that claimed the British-Swedish company’s Covid-19 vaccine showed little efficacy for people above 65.

Handelsblatt daily had reported on Monday that Berlin had estimated that the efficacy of the jab in people above 65 was just 8%, citing unnamed sources. Separately, Bild daily, quoting anonymous sources, put the efficacy rate at “less than 10%”.

But Germany’s Health Ministry said it appears that there have been some mix up in the reports.

“Around 8% of the volunteers in AstraZeneca’s efficacy studies were around 56 and 69 years old and three to 4% are above 70 years old,” said the Ministry.

“However, this does not mean that it is effective only in 8% of older people,” it added.

The company has also rejected the media reports on its vaccine efficacy in adults over 65 years as “completely incorrect”.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.


A one-stop-shop for seeing the latest updates, and managing your preferences.


We brief you on the latest and most important developments, three times a day.

Support Quality Journalism.

*Our Digital Subscription plans do not currently include the e-paper, crossword and print.

This article is auto-generated by Algorithm Source:


What do you think?